ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
64 276,44
0,60%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Repare Therapeutics Inc (RPTX)

  7. Repare Therapeutics Inc (RPTX) Actualités

RPTX Repare Therapeutics Inc

3,45
0,10 (2,99%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Repare Therapeutics Inc RPTX NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,10 2,99% 3,45 06:00:07
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
3,48 3,445 3,74 3,45 3,35
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
30/4/202413:05BWDEBIOPHARM ET REPARE THERAPEUTICS ANNONCENT LE TRAITEMENT..
26/4/202422:05BWRepare Therapeutics Appoints Steven H. Stein, M.D. to its..
05/3/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202403:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202403:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202413:05BWRepare Therapeutics to Participate in Two Upcoming Investor..
28/2/202422:09EDGAR2Form S-8 - Securities to be offered to employees in employee..
28/2/202413:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
28/2/202413:10EDGAR2Form 8-K - Current report
28/2/202413:05BWRepare Therapeutics Provides Business Update and Reports..
15/2/202413:05BWRepare Therapeutics Doses First Patient in Phase 1 Clinical..
15/2/202403:02EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/2/202414:54EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/2/202422:48EDGAR2Form 8-K - Current report
12/2/202422:05BWRepare Therapeutics to Regain Global Rights to Camonsertib
25/1/202420:29EDGAR2Form 8-K - Current report
25/1/202413:00BWRepare Therapeutics Announces Achievement of $40 Million..
12/1/202422:05EDGAR2Form 8-K - Current report
08/1/202413:00BWRepare Therapeutics Provides Corporate Update and Highlights..
04/1/202422:05BWRepare Therapeutics and Debiopharm Partner to Explore the..
29/12/202322:05BWRepare Therapeutics Insiders Establish Automatic Securities..
12/12/202322:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202313:20EDGAR2Form 8-K - Current report
15/11/202313:00BWRepare Therapeutics Unveils Two Programs Expected to Enter..
09/11/202313:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202313:05EDGAR2Form 8-K - Current report
09/11/202313:00BWRepare Therapeutics Provides Business Update and Reports..
07/11/202313:00BWRepare Therapeutics to Host Investor and Analyst Conference..
06/11/202313:00BWRepare Therapeutics to Participate in Two Upcoming Investor..
13/10/202323:15EDGAR2Form 8-K - Current report
13/10/202315:47EDGAR2Form 8-K - Current report
13/10/202315:40BWRepare Therapeutics Announces Positive Initial Data from..
06/10/202313:56EDGAR2Form 8-K - Current report
03/10/202313:00BWRepare Therapeutics to Host Conference Call and Webcast to..
19/9/202313:00BWRepare Therapeutics to Present Preliminary Phase 1 MYTHIC..
06/9/202313:00BWRepare Therapeutics to Participate at the Morgan Stanley..
09/8/202322:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202322:09EDGAR2Form 8-K - Current report
09/8/202322:05BWRepare Therapeutics Provides Business Update and Reports..
08/6/202313:00BWRepare Therapeutics to Participate at the Goldman Sachs 44th..
07/6/202322:05BWRepare Therapeutics Reports Proof of Concept for Lunresertib..
06/6/202313:00BWRepare Therapeutics Announces Publication in Nature Medicine..
02/6/202313:00BWRepare Therapeutics to Host Conference Call and Webcast to..
22/5/202313:00BWRepare Reports Inducement Grant Under Nasdaq Listing Rule..
09/5/202322:05BWRepare Therapeutics Provides Business Update and Reports..

Dernières Valeurs Consultées

NASDAQ
RPTX
Repare Therapeutics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés